You are here: Industry Insights > MSN

News List

MSN Laboratories launches Posaconazole to treat mucormycosis expresspharma
May 24, 2021
MSN has launched the product under the brand name PosaOne as 100 mg Delayed Release tablets and 300 mg injections, respectively.
Lilly signs licensing agreements with Dr Reddy’s, MSN Labs and Torrent Pharma for Baricitinib expresspharma
May 14, 2021
On May 10, Lilly had also announced the signing of three Voluntary License Agreements with Cipla, Lupin and Sun Pharma Industries.
MSN Laboratories launches Favilow (Faripiravir) 800 mg tablets expresspharma
April 29, 2021
The higher strength Favilow 800 mg is priced at Rs 144 per tablet and will be available across pharmacies.
Breckenridge Receives ANDA Approval for Asenapine Sublingual Tablets americanpharmaceuticalreview
March 12, 2021
Breckenridge Pharmaceutical announced the U.S. Food and Drug Administration (FDA)has granted final approval of its Abbreviated New Drug Application (ANDA) for Asenapine Sublingual Tablets in 5mg strength (generic for Saphris®).
MSN group gets US FDA nod for dimethyl fumarate capsules expresspharma
October 10, 2020
Dimethyl fumarate is a prescription medicine used to treat relapsing forms of multiple sclerosis in adults.
Discord between IMA and MSN Labs over promotion of COVID-19 drug, Favilow expresspharma
September 15, 2020
The doctors’ body claims misuse of its identity in the drug’s promotion while the pharma firm asserts that it has email expressing support from the former.
Novadoz/MSN Labs Receives FDA Clearance for Fosaprepitant, Decitabine americanpharmaceuticalreview
September 09, 2019
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India...
Plasticell receives EU funding to advance neurodegenerative disease research cphi-online
November 05, 2018
Th company's CombiCult combinatorial cell culture technology will be used to generate high fidelity, progenitor and terminally differentiated neuronal